# FDA Inspection 1158171 - Birth Tissue Recovery - October 21, 2021

Source: https://www.keypedia.com/records/fda_inspections/birth-tissue-recovery/bebf88d3-a8ec-4254-89fe-77dd1e843d56
Source feed: FDA_Inspections

> FDA Inspection 1158171 for Birth Tissue Recovery on October 21, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1158171
- Company Name: Birth Tissue Recovery
- Inspection Date: 2021-10-21
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1241796 - 2024-06-17](https://www.keypedia.com/records/fda_inspections/birth-tissue-recovery/80159ed4-97f5-46c9-9d1d-ccd92a8cfd19)
- [FDA Inspection 1158171 - 2021-10-21](https://www.keypedia.com/records/fda_inspections/birth-tissue-recovery/47c390f7-a4ce-4a23-ba2a-b505cd3377aa)
- [FDA Inspection 1158171 - 2021-10-21](https://www.keypedia.com/records/fda_inspections/birth-tissue-recovery/5daa160e-bb74-4c6d-a16c-dd6448bde225)

Company: https://www.keypedia.com/companies/birth-tissue-recovery/59d834fe-c60f-4f57-814f-04befa3251f0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d